Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 1.0
OSR Holdings, Inc. incurred loan of $75,000 with Jun Chul Whang at not interest bearing maturing the earlier of: (i) August 9, 2024 or (ii) the date on which the Company consummates an initial business combination.
- Instrument
- loan
- Principal
- $75,000
- Counterparty
- Jun Chul Whang
- Rate
- not interest bearing
- Maturity
- the earlier of: (i) August 9, 2024 or (ii) the date on which the Company consummates an initial business combination
- Event
- incurrence
Exact text from the filing
On February 9, 2024, Bellevue Life Sciences Acquisition Corp. (the “ Company ”) issued an unsecured promissory note (the “ Promissory Note ”) in the principal amount of $75,000 to Jun Chul Whang, a member of the Company’s Board of Directors (the “ Board ”).
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.95
OSR Holdings, Inc.: Stockholders approved a proposal to allow the Board to amend the Certificate of Incorporation to extend the deadline for consummating a business combination from February 14, 2024 to May 14, 2024 (effective 2024-02-09).
- Change
- charter amendment
- Effective
- 2024-02-09
Exact text from the filing
At the special meeting of the Company’s stockholders held on November 9, 2023, the stockholders approved a proposal to give the Board the authority, in its discretion, to amend the Company’s Certificate of Incorporation (the “ Charter ”) to extend the date by which the Company must consummate a business combination from the February 14, 2024 to May 14, 2024. The Board authorized and approved a Certificate of Amendment to the Company’s Charter (the “ Charter Amendment ”) and the Charter Amendment was filed with the Delaware Secretary of State and has an effective date of February 9, 2024.
View on SEC.gov